David Jacoby

1.5k total citations · 1 hit paper
26 papers, 1.1k citations indexed

About

David Jacoby is a scholar working on Physiology, Rheumatology and Molecular Biology. According to data from OpenAlex, David Jacoby has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 8 papers in Rheumatology and 7 papers in Molecular Biology. Recurrent topics in David Jacoby's work include Lysosomal Storage Disorders Research (11 papers), Glycogen Storage Diseases and Myoclonus (8 papers) and Cellular transport and secretion (6 papers). David Jacoby is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Glycogen Storage Diseases and Myoclonus (8 papers) and Cellular transport and secretion (6 papers). David Jacoby collaborates with scholars based in United States, Germany and Italy. David Jacoby's co-authors include Temitayo Ajayi, Angela Schulz, Peter Slasor, Alfried Kohlschütter, Michael B. A. Oldstone, Paul Gissen, Nicola Specchio, Emily de los Reyes, Heather Cahan and Douglas Ballon and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

David Jacoby

26 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Study of Intraventricular Cerliponase Alfa for CLN2 Disease

2018 310 citations Angela Schulz, Temitayo Ajayi et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Jacoby United States	14	347	325	316	215	191	26	1.1k
Alessandra Cervino United Kingdom	16	136 0.4×	407 1.3×	263 0.8×	146 0.7×	139 0.7×	19	891
Jun Ohashi Japan	21	139 0.4×	340 1.0×	428 1.4×	210 1.0×	37 0.2×	55	1.2k
Sharon McGrath United States	10	145 0.4×	675 2.1×	438 1.4×	82 0.4×	97 0.5×	13	1.4k
Kati J. Buckingham United States	15	105 0.3×	999 3.1×	951 3.0×	89 0.4×	80 0.4×	29	1.9k
Peter F. Jezyk United States	24	557 1.6×	543 1.7×	362 1.1×	232 1.1×	51 0.3×	52	1.6k
Andreas Ohlenbusch Germany	20	85 0.2×	633 1.9×	215 0.7×	66 0.3×	256 1.3×	49	1.2k
Mary O. Smith United States	18	218 0.6×	268 0.8×	56 0.2×	227 1.1×	143 0.7×	26	1.2k
Anthi Drousiotou Cyprus	14	188 0.5×	465 1.4×	368 1.2×	80 0.4×	21 0.1×	47	1.1k
M. A. Thrall United States	19	395 1.1×	178 0.5×	147 0.5×	109 0.5×	34 0.2×	28	896
Travis Ptacek United States	22	131 0.4×	660 2.0×	160 0.5×	132 0.6×	118 0.6×	45	1.3k

Countries citing papers authored by David Jacoby

Since Specialization

Citations

This map shows the geographic impact of David Jacoby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jacoby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jacoby more than expected).

Fields of papers citing papers by David Jacoby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Jacoby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jacoby. The network helps show where David Jacoby may publish in the future.

Co-authorship network of co-authors of David Jacoby

This figure shows the co-authorship network connecting the top 25 collaborators of David Jacoby. A scholar is included among the top collaborators of David Jacoby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Jacoby. David Jacoby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Aryun, Anita Grover, Peter Slasor, et al.. (2020). Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clinical and Translational Science. 14(2). 635–644. 7 indexed citations

Mulberg, Andrew E., Christina Bucci‐Rechtweg, Joseph Giuliano, et al.. (2019). Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders. Orphanet Journal of Rare Diseases. 14(1). 36–36. 37 indexed citations

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2019). Persistent Treatment Effect of Cerliponase Alfa in Children with CLN2 Disease: A 3 Year Update from an Ongoing Multicenter Extension Study. Neuropediatrics. 6 indexed citations

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2019). Persistent treatment effect of cerliponase alfa in children with CLN2 disease: A 3 year update from an ongoing multicenter extension study. Molecular Genetics and Metabolism. 126(2). S133–S133. 6 indexed citations

Nickel, Miriam, Alessandro Simonati, David Jacoby, et al.. (2018). Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. The Lancet Child & Adolescent Health. 2(8). 582–590. 89 indexed citations

Schulz, Angela, Temitayo Ajayi, Nicola Specchio, et al.. (2018). Study of Intraventricular Cerliponase Alfa for CLN2 Disease. New England Journal of Medicine. 378(20). 1898–1907. 310 indexed citations breakdown →

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2017). Intracerebroventricular cerliponase alfa for children with CLN2 disease: Interim results from an ongoing phase 2 extension study. European Journal of Paediatric Neurology. 21. e21–e21. 2 indexed citations

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2017). Long-term safety and efficacy of intracerebroventricular enzyme replacement therapy with cerliponase alfa in children with CLN2 disease: interim results from an ongoing multicenter, multinational extension study. Molecular Genetics and Metabolism. 120(1-2). S120–S120. 2 indexed citations

Reyes, Emily de los, Angela Schulz, Nicola Specchio, et al.. (2016). Intracerebroventricular Cerliponase Alfa (BMN 190) in Children with CLN2 disease: Results from a Phase 1/2, Open-Label, Dose-Escalation Study. 5 indexed citations

10.

Fraefel, Cornel, David Jacoby, & Xandra O. Breakefield. (2000). Herpes simplex virus type 1-based amplicon vector systems. Advances in virus research. 55. 425–451. 22 indexed citations

11.

Jacoby, David, Peter Pecháň, Cornel Fraefel, et al.. (1997). HSV/AAV Hybrid Amplicon Vectors Extend Transgene Expression in Human Glioma Cells. Human Gene Therapy. 8(3). 359–370. 108 indexed citations

12.

Smith, Frances I., David Jacoby, & Xandra O. Breakefield. (1995). Virus vectors for gene delivery to the nervous system. Restorative Neurology and Neuroscience. 8(1-2). 21–34. 13 indexed citations

13.

Jacoby, David, et al.. (1993). Expression of the La Crosse M Segment Proteins in a Recombinant Vaccinia Expression System Mediates pH-Dependent Cellular Fusion. Virology. 193(2). 993–996. 28 indexed citations

14.

González‐Scarano, Francisco, David Jacoby, Christian Griot, & Neal Nathanson. (1992). Genetics, infectivity and virulence of California serogroup viruses. Virus Research. 24(2). 123–135. 12 indexed citations

15.

Chandler, Laura J., Gary S. Hogge, M. Endres, et al.. (1991). Reassortment of La Crosse and Tahyna bunyaviruses in Aedes triseriatus mosquitoes. Virus Research. 20(2). 181–191. 26 indexed citations

16.

Endres, M., et al.. (1989). The Large Viral RNA Segment of California Serogroup Bunyaviruses Encodes the Large Viral Protein. Journal of General Virology. 70(1). 223–228. 44 indexed citations

17.

Jacoby, David, et al.. (1988). Use of a resonance energy transfer assay to investigate the fusion function of La Crosse virus. Virus Research. 11. 11–11. 3 indexed citations

18.

Southern, Peter J., Mandaleshwar K. Singh, Yves Rivière, et al.. (1987). Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology. 157(1). 145–155. 94 indexed citations

19.

Jacoby, David, Lars B. Olding, & Michael B. A. Oldstone. (1984). Immunologic Regulation of Fetal-Maternal Balance. Advances in immunology. 35. 157–208. 68 indexed citations

20.

Jacoby, David & M B Oldstone. (1983). Delineation of suppressor and helper activity within the OKT4-defined T lymphocyte subset in human newborns.. The Journal of Immunology. 131(4). 1765–1770. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact